Thomas C. Chen
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Axel H. Schönthal (76 shared papers)Florence M. Hofman (67 shared papers)Stan G. Louie (17 shared papers)Weijun Wang (39 shared papers)Martin H. Weiss (10 shared papers)Peter Pyrko (6 shared papers)Encouse B. Golden (11 shared papers)Nicos A. Petasis (14 shared papers)
- Journals
- Neurosurgical FOCUS (21 papers)Journal of neurosurgery (17 papers)Neurosurgery (13 papers)Cancer Letters (11 papers)Molecular Cancer Therapeutics (7 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Thomas C. Chen
176 papers receiving 9k citations
Thomas C. Chen's Hit Papers
Peers
Comparison fields: 5 of 138
- Genetics 2.1k
- Biomaterials 1.2k
- Cell Biology 668
- Cancer Research 374
- Pathology and Forensic Medicine 446
Countries citing papers authored by Thomas C. Chen
This map shows the geographic impact of Thomas C. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Chen more than expected).
Fields of papers citing papers by Thomas C. Chen
This network shows the impact of papers produced by Thomas C. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Chen. The network helps show where Thomas C. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas C. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanoparticle biointerfacing by platelet membrane cloaking Hit paper breakdown → | 2015 | 1630 |
| 2 | Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma Hit paper breakdown → | 2015 | 1049 |
| 3 | 2007 | 392 | |
| 4 | 2009 | 231 | |
| 5 | 1998 | 207 | |
| 6 | 1994 | 174 | |
| 7 | 2012 | 173 | |
| 8 | 2018 | 160 | |
| 9 | 2014 | 152 | |
| 10 | 2015 | 152 | |
| 11 | 2008 | 139 | |
| 12 | 2014 | 125 | |
| 13 | 2007 | 121 | |
| 14 | 2008 | 115 | |
| 15 | 2007 | 111 | |
| 16 | 1995 | 104 | |
| 17 | 2005 | 104 | |
| 18 | 2012 | 102 | |
| 19 | Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy. | 2015 | 102 |
| 20 | 1992 | 99 |
About Thomas C. Chen
Thomas C. Chen is a scholar working on Genetics, Neurology, Epidemiology, Cell Biology and Neurology, having authored 182 papers that have together received 9.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (56 papers), Meningioma and schwannoma management (13 papers), Angiogenesis and VEGF in Cancer (13 papers), Endoplasmic Reticulum Stress and Disease (11 papers), Barrier Structure and Function Studies (10 papers), Virus-based gene therapy research (8 papers), Autophagy in Disease and Therapy (7 papers) and Spinal Fractures and Fixation Techniques (5 papers). The work is most often cited by research in Genetics (2.1k citations), Biomaterials (1.2k citations), Cell Biology (668 citations), Cancer Research (374 citations) and Pathology and Forensic Medicine (446 citations). Thomas C. Chen has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Axel H. Schönthal, Florence M. Hofman, Stan G. Louie, Weijun Wang, Martin H. Weiss, Peter Pyrko, Encouse B. Golden, Nicos A. Petasis, Adel Kardosh and William T. Couldwell. Their work appears in journals such as Neurosurgical FOCUS, Journal of neurosurgery, Neurosurgery, Cancer Letters and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.